The Undifferentiated Medical Student Ep 014 - Infectious Diseases with Dr. Robert Kalayjian
Dec 30, 2016
Dr. Robert Kalayjian, Director of Infectious Diseases and HIV/TB researcher and teacher. He discusses why he chose infectious disease, a typical week balancing clinics, inpatient consults, research and teaching. He describes memorable diagnostic puzzles, public hospital realities, evolving diagnostics and drug pipelines, and advice for students exploring the field.
AI Snips
Chapters
Books
Transcript
Episode notes
Molecular Tests And Sicker Outpatients Will Reshape ID
- Molecular diagnostics and outpatient management of sicker patients will reshape ID over 10–20 years.
- Kalayjian predicts culture-based methods will be supplanted by molecular tests while more patients receive IV therapy and complex care at home.
Antibacterial Pipeline Is Slowing While Resistance Grows
- Antibiotic development lags while antivirals have expanded, leaving multidrug resistance as a major concern.
- Kalayjian notes a slowdown in antibacterial pipelines but progress in antivirals and new drugs for multidrug-resistant TB and bacteria.
Public Hospital Care Requires Extra Follow Up
- Working in a public hospital means patients often present later and lack primary care, so ID clinicians must provide more follow-up and care coordination.
- Kalayjian explains MetroHealth patients present with advanced disease and require extra outpatient management.
